Methods for determining reactive index for cement kiln dust, associated compositions and methods of use

Abstract
A variety of methods and compositions are disclosed, including, in one embodiment, a method of treating a well comprising: providing a treatment fluid comprising a base fluid and a blended cementitious component, wherein the blended cementitious component comprises kiln dust from two or more different sources; and introducing the treatment fluid into a well bore.
Description
BACKGROUND

The present invention relates to cementitious components and, more particularly, in certain embodiments, to methods of determining a reactive index for cementitious components.


In general, well treatments include a wide variety of methods that may be performed in oil, gas, geothermal and/or water wells, such as drilling, completion and workover methods. The drilling, completion and workover methods may include, but are not limited to, drilling, fracturing, acidizing, logging, cementing, gravel packing, perforating and conformance methods. Many of these well treatments are designed to enhance and/or facilitate the recovery of desirable fluids from a subterranean well. These fluids may include hydrocarbons such as oil and/or gas.


In cementing methods, such as well construction and remedial cementing, settable compositions are commonly utilized. As used herein, the term “settable composition” refers to a composition(s) that hydraulically sets or otherwise develops compressive strength. Settable compositions may be used in primary cementing operations whereby pipe strings, such as casing and liners, are cemented in well bores. In performing primary cementing, a settable composition may be pumped into an annulus between a subterranean formation and the pipe string disposed in the subterranean formation or between the pipe string and a larger conduit disposed in the subterranean formation. The settable composition should set in the annulus, thereby forming an annular sheath of hardened cement (e.g., a cement sheath) that should support and position the pipe string in the well bore and bond the exterior surface of the pipe string to the walls of the well bore or to the larger conduit. Settable compositions also may be used in remedial cementing methods, such as the placement of cement plugs, and in squeeze cementing for sealing voids in a pipe string, cement sheath, gravel pack, formation, and the like. Settable compositions may also be used in surface applications, for example, construction cementing.


Settable compositions for use in subterranean formations may typically include a cementitious component which hydraulically sets, or otherwise hardens, to develop compressive strength. Examples of cementitious components that can be included in settable compositions include Portland cement, calcium aluminate cement, cement kiln dust, lime kiln dust, fly ash, slag, pumice, and rice-hull ash, among others. The performance of these different cementitious components in settable compositions may vary and can even vary for a particular cementitious component depending, for example, on the particular type or source of the component. For example, certain of these cementitious components may have undesirable properties that can make them unsuitable for use in well treatments. In addition, variation of the performance for the cementitious components can lead to lack of predictability and consistency for the cementitious components when used in treatment fluids. This lack of predictability consistency may even be apparent for the same cementitious component, for example, if sourced from different locations.


SUMMARY

The present invention relates to cementitious components and, more particularly, in certain embodiments, to methods of determining a reactive index for cementitious components.


An embodiment discloses a method of treating a well comprising: providing a treatment fluid comprising a base fluid and a blended cementitious component, wherein the blended cementitious component comprises kiln dust from two or more different sources; and introducing the treatment fluid into a well bore.


Another embodiment discloses a method of cementing comprising: providing a settable composition comprising water and a blended cementitious component, wherein the blended cementitious component comprises kiln dust from two or more different sources; and allowing the settable composition to set to form a hardened mass.


Another embodiment discloses a method of cementing comprising: providing a settable composition comprising water and a blended cementitious component, wherein the blended cementitious component comprises kiln dust and an additional cementitious component, the kiln dust and the additional cementitious component each have a determined reactive index; and allowing the settable composition to set to form a hardened mass.


Another embodiment discloses a method of preparing a blended cementitious component comprising: providing a first kiln dust, the first kiln dust being from a first source; providing a second kiln dust, the second kiln dust being from a second source; and blending at least the first kiln dust and the second kiln dust to form the blended cementitious component.


Another embodiment discloses a method of measuring reactivity of a kiln dust comprising: measuring a parameter of the kiln dust, the kiln dust having a specific surface area; and dividing the measured parameter by the specific surface area of the kiln dust to obtain a reactive index for the kiln dust.


Another embodiment discloses a well treatment fluid comprising: a base fluid; and a blended cementitious component comprising kiln dust from two or more different sources.


The features and advantages of the present invention will be readily apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.





BRIEF DESCRIPTION OF THE DRAWINGS

These drawings illustrate certain aspects of some of the embodiments of the present invention, and should not be used to limit or define the invention.



FIG. 1 is a chart showing measured reactive indexes for various supply sources of cement kiln dust.



FIG. 2 is a chart comparing actual versus predicted compressive strength for dry blends of cement kiln dust.



FIG. 3 is a chart comparing actual versus predicted volume average apparent viscosity at 511 sec−1 for dry blends of cement kiln dust.



FIG. 4 is a chart comparing actual versus predicted volume average apparent viscosity at 51 sec−1 for dry blends of cement kiln dust.





DESCRIPTION OF PREFERRED EMBODIMENTS

The present invention relates to cementitious components and, more particularly, in certain embodiments, to methods of determining a reactive index for cementitious components. By determining the reactive index for cementitious components, blends of cementitious components may be used in well treatments, according to particular embodiments, that can provide more predictable and consistent performance. In addition, additional embodiments may include using the determined reactive index to provide blends of cementitious components in which one or more parameters have been optimized, including compressive strength, Young's Modulus, fluid loss, and/or thickening time, for example.


Without being limited by theory, the reactive index of a cementitious component may be referred to as a measure of the cementitious component's reactivity as adjusted for differences in surface area. Example techniques for determining the reactive index may comprise measuring a parameter of the cementitious component, and then dividing the measured parameter by the specific surface area of the cementitious component. In some embodiments, the reactive index for a cementitious component may be calculated in accordance with the following equation:

RI=MP/SSA

wherein RI is the reactive index, MP is the measured parameter of the cementitious component, and SSA is the specific surface area of the cementitious component. In general, specific surface area is a property of a particulate solid and, as used herein, is defined as the total surface area of the cementitious component divided by the mass of the cementitious component or the total surface area divided by the bulk volume of the cementitious component.


In general, cementitious components are particulate solids that hydraulically set, or otherwise harden, to develop compressive strength in the presence of water. Non-limiting examples of cementitious components that may be suitable for use in embodiments of the present invention include Portland cements, calcium aluminate, gypsum, pozzolanic materials, and kiln dust. Mixtures of one or more different cementitious components may also be used. In some embodiments, the cementitious component may be combined with lime.


In some embodiments, the cementitious component may comprise Portland cement. Portland cement is a commonly used cementitious component that hydraulically reacts with water to develop compressive strength. Examples of suitable Portland cements may include those classified as Classes A, C, G and H cements according to American Petroleum Institute, API Specification for Materials and Testing for Well Cements, API Specification 10, Fifth Edition, Jul. 1, 1990. In addition, Portland cements suitable for use in embodiments of the present invention may also include those classified as ASTM Type I, I/II, II, III, IV, or V. In some embodiments, blends of cementitious components containing Portland cement may be used.


In some embodiments, the cementitious component may comprise a calcium aluminate. Calcium aluminate may hydraulically react with water to develop compressive strength. Calcium aluminate may be included in cements commonly referred to as calcium aluminate cements or high alumina content cements. Calcium aluminate cements may be prepared in a manufacturing process that includes mixing a calcium bearing material (e.g., limestone) and an aluminum-bearing material (e.g., bauxite).


In some embodiments, the cementitious component may comprise gypsum. Gypsum is a material that sets in the presence of water to develop compressive strength. Gypsum may be included in cements commonly referred to as gypsum cements. For use in cements, gypsum may, in some instances, be burned at extremely high temperatures and then ground. In particular embodiments, gypsum may be added to Portland cement.


In some embodiments, the cementitious component may comprise a pozzolanic material. Pozzolanic materials that may be suitable for use include a wide variety of natural or artificial materials that exhibit cementitious properties in the presence of calcium hydroxide. Examples of suitable pozzolanic material that may be suitable for use in embodiments of the present invention include natural and artificial pozzolans, such as fly ash, silica fume, slag, burned shale, burned clay, metakaolin, pumice, diatomaceous earth, volcanic ash, opaline shale, tuff, and burned organic materials, such as agricultural waste ash, municipal waste ash (e.g., municipal solid waste ash), waste-water treatment waste ash, animal waste ash, non-human-non-animal industrial waste ash, and combinations thereof. Specific examples of agricultural waste ash include, for example, rice husk ash, wood (e.g., sawdust, bark, twigs, branches, other waste wood) ash, tree leave ash, corn cob ash, cane (e.g., sugar cane) ash, bagasse ash, grain (e.g., amaranth, barley, corn flaxseed, millet, oat, quinoa, rye, wheat etc.) and related by-product(s) (e.g., husks, hulls, etc.) ash, orchard ash, vine trimming ash, grass (e.g., Korai, Tifton, native shiba, etc.) ash, straw ash, ground nut shell ash, legume (e.g., soybean) ash, and combinations thereof.


In some embodiments, the cementitious component may comprise a kiln dust. One example of a kiln dust includes cement kiln dust. Cement kiln dust, as that term is used herein, refers to a partially calcined kiln feed which is removed from the gas stream and collected, for example, in a dust collector during the manufacture of cement. The cement kiln dust generally may exhibit cementitious properties, in that it may set and harden in the presence of water. Usually, large quantities of cement kiln dust are collected in the production of cement that are commonly disposed of as waste. Disposal of the cement kiln dust can add undesirable costs to the manufacture of the cement, as well as the environmental concerns associated with its disposal. The chemical analysis of the cement kiln dust from various cement manufactures varies depending on a number of factors, including the particular kiln feed, the efficiencies of the cement production operation, and the associated dust collection systems. Cement kin dust generally may comprise a variety of oxides, such as SiO2, Al2O3, Fe2O3, CaO, MgO, SO3, Na2O, and K2O. Another example of a kiln dust includes lime kiln dust. Lime kiln dust, as that term is used herein, refers to a product generated in the manufacture of lime. The lime kiln dust may be collected, for example, by dust control systems in the calcination of lime stone.


In some embodiments, one or more parameters of the cementitious component may be measured and then used in determining the reactive index. The parameters may include a number of different parameters that may be measured using standard laboratory testing techniques for a settable composition comprising a cementitious component and water. Additional components may also be included in the settable compositions, for example, to vary one or more properties of the treatment fluid. Parameters of the cementitious component, or settable composition contained therein, that may be measured include, for example, compressive strength, Young's Modulus, fluid loss, thickening time, rheological values (e.g., volume average apparent viscosity, plastic viscosity, yield point, etc.) and/or free water.


Compressive strength is generally the capacity of a material or structure to withstand axially directed pushing forces. The compressive strength of the cementitious component may be measured at a specified time after the cementitious component has been mixed with water and the resultant treatment fluid is maintained under specified temperature and pressure conditions. For example, compressive strength can be measured at a time in the range of about 24 to about 48 hours after the fluid is mixed and the fluid is maintained at a temperature of 170° F. and atmospheric pressure. Compressive strength can be measured by either a destructive method or non-destructive method. The destructive method physically tests the strength of treatment fluid samples at various points in time by crushing the samples in a compression-testing machine. The compressive strength is calculated from the failure load divided by the cross-sectional area resisting the load and is reported in units of pound-force per square inch (psi). Non-destructive methods typically may employ an Ultrasonic Cement Analyzer (“UCA”), available from Fann Instrument Company, Houston, Tex. Compressive strengths may be determined in accordance with API RP 10B-2, Recommended Practice for Testing Well Cements, First Edition, July 2005.


Young's modulus also referred to as the modulus of elasticity is a measure of the relationship of an applied stress to the resultant strain. In general, a highly deformable (plastic) material will exhibit a lower modulus when the confined stress is increased. Thus, the Young's modulus is an elastic constant that demonstrates the ability of the tested material to withstand applied loads. A number of different laboratory techniques may be used to measure the Young's modulus of a treatment fluid comprising a cementitious component after the treatment fluid has been allowed to set for a period of time at specified temperature and pressure conditions.


Fluid loss typically refers to loss of a fluid such as a treatment fluid into a subterranean formation. A number of different laboratory techniques may be used to measure fluid loss of a treatment fluid to give an indication of the behavior of the treatment fluid in a well. Fluid loss may be measured using a static fluid-loss test, with either a static or stirred fluid-loss cell, in accordance with the afore-mentioned API RP Practice 10B-2.


Thickening time typically refers to the time a fluid, such as a treatment fluid, comprising the cementitious component, remains in a fluid state capable of being pumped. A number of different laboratory techniques may be used to measure thickening time to give an indication of the amount of time a treatment fluid will remain pumpable in a well. An example technique for determining whether a treatment fluid is in a pumpable fluid state may use a high-temperature high-pressure consistometer at specified pressure and temperature conditions, in accordance with the procedure for determining cement thickening times set forth in the afore-mentioned API RP Practice 10B-2. The thickening time may be the time for the treatment fluid to reach 70 Bearden units of consistency (“Bc”) and may be reported in time to reach 70 Bc.


Rheological values of a fluid may be determined to characterize the fluid's rheological behavior. Rheological values that may be determined include volume average apparent viscosity, yield point and plastic viscosity, among others. Plastic viscosity is typically a measure of the resistance of a fluid to flow. In some embodiments, the yield point may be a parameter of the Bingham plastic model, the yield point being the slope of the shear stress/shear rate line above the yield point. Yield point is typically a measure of the point at which a material can no longer deform elastically. In some embodiments, the yield point may be a parameter of the Bingham plastic model, the yield point being the yield stress extrapolated to a shear rate of zero. A number of different laboratory techniques may be used to measure rheological values of a treatment fluid to give an indication of the behavior of the treatment fluid in a well. Rheological values may be determined in accordance with the procedure set forth in API RP Practice 10B-2.


Free water typically refers to any water in a fluid that is in excess to what is required to fully hydrate the components of the fluid. Free water can be undesired as it may physically separate from a cement composition as it sets. Free water may also be referred to as free fluid. A number of different laboratory techniques may be used to measure free water of a treatment fluid to give an indication of the behavior of the treatment fluid in a well. Free water may be determined in accordance with the procedure set forth in API RP Practice 10B-2.


As previously mentioned, the reactivity of cementitious components may vary between different types of cementitious components or even between different sources for a particular type of cementitious component. For example, the reactivity of Portland cement and another cementitious component, such as a pozzolanic material, may be different. By way of further example, the reactivity of a cementitious component may vary between different sources for the cementitious component. In some embodiments, the reactive index of the cementitious component may vary between two or more different sources by a factor of at least about 2:1. For example, the reactive index of the cementitious component between different sources may vary by an amount between any of and/or including any of about 2:1, about 10:1, about 50:1, about 100:1, about 250:1, about 500:1, or about 1000:1. Because the reactivity varies between different cementitious components and even between different sources for a cementitious component, the performance of different cementitious components may be unpredictable and may also lead to a lack of consistency for the cementitious components when used in treatment fluids such as settable compositions. In some instances, the performance of a particular cementitious component may have undesirable properties, which may make it unsuitable for use. For example, a cementitious component from a particular source may have properties making it undesirable for use.


In some embodiments, a blend of two or more different cementitious components may be used to provide a blended cementitious component that may have properties suitable for use in a particular application. This may be particularly useful, for example, where one of the cementitious components in the blend may have properties making it unsuitable for particular applications. For example, a cementitious component such as cement kiln dust from a first source may be blended with a cementitious component such as cement kiln dust from a second source. In some embodiments, one or both of the cementitious components may have reactivities that are unsuitable for a particular application. For example, the reactivities of each cementitious component may be individually too slow or too fast for a particular application. The blends of the cementitious component from the two different sources may form a blended cementitious component having compressive strength properties that are suitable for the application. In some embodiments, the relative proportions (e.g., weight fractions) of each cementitious component in the blended cementitious component may then be adjusted to adjust the compressive strength properties of the blended cementitious component.


The two or more cementitious components in the blended cementitious component may include, for example, two or more different types of cementitious components, such as Portland cement and cement kiln dust. Alternatively, the two or more cementitious components in the blended cementitious component may include, for example, a cementitious component from two or more different sources. For example, a first cementitious component may comprise cement kiln dust from a first source, and the second cementitious component may comprise cement kiln dust from a second source. It should be understood that embodiments are not limited to only two different sources, but may include a cementitious component, such as cement kiln dust, from three, four, five, or even more different sources. The two or more different sources for the cementitious component may include different manufactures, different cement manufacturing plants, and the like. A cementitious component, such as cement kiln dust which is a byproduct from the cement manufacturing plant, may have a number of different sources available throughout the world. For example, different sources for cement kiln dust may include different manufacturing plants throughout the world at which cement kiln dust can be generated.


The two or more cementitious components may be blended to form the blended cementitious component, for example, prior to combination with water and/or other components of the treatment fluid. In particular embodiments, the two or more cementitious components may be dry blended to form a dry blend comprising the two or more cementitious components. The dry blend may then be combined with water and/or other components, in any order, to form the treatment fluid. However, the use of the term “blend” is not intended to imply that the two or more cementitious components have been dry blended prior to combination with water. For example, the blend of two or more cementitious components may not be combined until after one, or even both, of the cementitious components has already been blended with water.


In some embodiments, the reactive index may be used to optimize the blended cementitious component, wherein the blended cementitious component comprises two or more cementitious components. For example, the reactive index may be used to optimize one or more parameters of the blended cementitious component, including compressive strength, Young's Modulus, fluid loss, and/or thickening time. Optimizing the blended cementitious component may include determining the reactive index for each of the cementitious components in the blended cementitious component. The reactive indexes for the cementitious components may then be used to predict the performance of the blended cementitious component. The ratio of each cementitious component may be adjusted to optimize the performance of the blended cementitious component. The performance of the blended cementitious component may be optimized with the performance of the blended cementitious component estimated using the following equation:







EP
blend

=




i
=
1

n




(

RI
i

)



(

SSA
i

)




(

f
i

)

m








Wherein EPblend is the estimated parameter for the blended cementitious component, i is the individual cementitious component from the set of cementitious components 1 to n, n is an integer, RIi is the reactive index for cementitious component iSSAi is the specific surface area for cementitious component i, fi is the mass fraction of the cementitious component I, and m is a number from 1 to 10. The set of cementitious components may include 2 or more different cementitious components. The two or more different cementitious component may be different types of cementitious components, such as Portland cement and slag, or may be from different sources, such as cement kiln dust from a first source and cement kiln dust from a second source. In some embodiments, m may be 1. In alternative embodiments, m may be 7/3.


In some embodiments, the mean particle size of the cementitious component may be altered from its original particle size. The reactive index may then be measured for the altered cementitious component. The altered cementitious component may be included in a blended cementitious component. In accordance with present embodiments, the mean particle size of the cementitious component can be altered using any suitable technique, including, without limitation, grinding or separating to provide a material having an altered particle size. Separating the cementitious component may include sieving or any other suitable technique for separating the cementitious component to provide a mean particle size that has been altered from its original size. For example, sieving may be used to produce cementitious component having an increased or reduced mean particle size as desired for a particular application. By way of further example, grinding may be used to decrease the mean particle size of the cementitious component. Combinations of grinding and separating may be used in some embodiments. The term “ground” or “grinding” as used herein means using a grinder (e.g., ball mill, rod mill, etc.) to reduce the particle size of the specified component(s). An example of a suitable grinder is an 8000 Mixer/Mill® ball mill, available from SPEX Sample Prep. In some embodiments, the cementitious component may be ground for a time period in a range of from about 30 minutes to about 1 hour.


The mean particle size of the cementitious component can be altered to any size suitable for use in cementing operations. In some embodiments, the mean particle size of the cementitious component may be altered from its original particle size to have a mean particle size in a range of about 1 micron to about 350 microns. The mean particle size corresponds to d50 values as measured by particle size analyzers such as those manufactured by Malvern Instruments, Worcestershire, United Kingdom.


In some embodiments, the mean particle size of the cementitious component may be increased from its original size. For example, the mean particle size of the cementitious component may be at least 5% greater than its original size. In some embodiments, at least a portion of the cementitious component may be increased to a size that is in a range of from about 5% to about 500% greater than its original size. In some embodiments, the mean particle size may be increased to a size ranging between any of and/or including any of about 5%, about 10%, about 20%, about 30%, about 40%, about 50%, about 60%, about 70%, about 80%, about 90%, about 100%, about 200%, about 300%, about 400%, or about 500% greater than its original size.


In some embodiments, the mean particle size of the cementitious component may be reduced from its original size. For example, the mean particle size may be reduced in an amount sufficient to increase the compressive strength of the cementitious component. In some embodiments, the cementitious component may have a mean particle size that is at least 5% less than its original size. In some embodiments, at least a portion of the cementitious component may be reduced to have a mean particle size in a range of from about 5% to about 95% of its original size. For example, the mean particle size may be reduced to a size ranging between any of and/or including any of about 5%, about 10%, about 15%, about 20%, about 25%, about 30%, about 35%, about 40%, about 45%, about 50%, about 55%, about 60%, about 6%, about 70%, about 75%, about 80%, about 90%, or about 95% of its original size. By way of example, the reduced particle size cementitious component may have a mean particle size of less than about 15 microns. In some embodiments, the reduced particle size cementitious component may have a mean particle size of less than about 10 microns, less than about 5 microns, less than about 4 microns, less than about 3 microns, less than about 2 microns, or less than about 1 micron. In specific embodiments, the reduced particle size cementitious component may have a mean particle size in a range of from about 0.1 microns to about 15 microns, from about 0.1 microns to about 10 microns, or from about 1 micron to about 10 microns. One of ordinary skill in the art, with the benefit of this disclosure, should be able to select a particle size for the cementitious component suitable for a particular application.


In some embodiments, the mean particle size of the cement kiln dust may be reduced in an amount sufficient to provide an increase in compressive strength for the settable composition. For example, the mean particle size may be reduced to provide an increase in compressive strength of at least about 5%, about 25%, about 50%, about 75%, or about 100%.


In accordance with present embodiments, the cementitious components may be included in treatment fluids that can be used in a variety of operations that may be performed in subterranean formations. The cementitious component may have reactive index calculated according to disclosed embodiments. In some embodiments, a blended cementitious component may be used. In some embodiments, the reactive index may be used in determining the cementitious components in a particular blended cementitious component. As referred to herein, the term “treatment fluid” will be understood to mean any fluid that may be used in a subterranean application in conjunction with a desired function and/or for a desired purpose. The term “treatment fluid” is not intended to imply any particular action by the fluid. Treatment fluids often are used in, e.g., well drilling, completion, and stimulation operations. Examples of such treatment fluids include drilling fluids, well cleanup fluids, workover fluids, conformance fluids, gravel pack fluids, acidizing fluids, fracturing fluids, cement compositions, spacer fluids, and the like.


While embodiments of the compositions and methods may be used in a variety of applications, they may be particularly useful for subterranean well completion and remedial operations, such as primary cementing of casings and liners in well bores. They also may be useful for surface cementing operations, including construction cementing operations. Accordingly, embodiments of the present invention disclose settable compositions comprising a cementitious component and water.


The cementitious component may be included in embodiments of the settable compositions in an amount suitable for a particular application. In some embodiments, the cementitious component may comprise cement kiln dust. The cement kiln dust may be present in an amount in a range of from about 0.01% to 100% by weight of the cementitious component (“bwoc”). For example, the cement kiln dust may be present in an amount ranging between any of and/or including any of about 0.01%, about 5%, about 10%, about 20%, about 30%, 40%, about 50%, about 60%, about 70%, about 80%, about 90%, or about 100%. The cementitious component may be free or essentially free (for example, no more than 1% by weight of the cementitious component) of any additional cementitious components other than the cementitious component. In some embodiments, the cementitious component may be essentially free of Portland cement. One of ordinary skill in the art with the benefit of this disclosure should be able to determine an appropriate amount of the cementitious component to include for a particular application.


The water used in embodiments of the settable compositions of the present invention may include, for example, freshwater, saltwater (e.g., water containing one or more salts dissolved therein), brine (e.g., saturated saltwater produced from subterranean foil nations), seawater, or any combination thereof. Generally, the water may be from any source, provided, for example, that it does not contain an excess of compounds that may undesirably affect other components in the settable composition. In some embodiments, the water may be included in an amount sufficient to form a pumpable slurry. In some embodiments, the water may be included in the settable compositions of the present invention in an amount in a range of from about 40% to about 200% bwoc. For example, the water may be present in an amount ranging between any of and/or including any of about 50%, about 75%, about 100%, about 125%, about 150%, or about 175% by weight of the cement. In specific embodiments, the water may be included in an amount in the range of from about 40% to about 150% bwoc. One of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate amount of water to include for a chosen application.


Other additives suitable for use in subterranean cementing operations may also be added to embodiments of the settable compositions, in accordance with embodiments of the present invention. Examples of such additives include, but are not limited to, fluid-loss-control additive, set retarder, strength-retrogression additives, set accelerators, weighting agents, lightweight additives, gas-generating additives, mechanical-property-enhancing additives, lost-circulation materials, filtration-control additives, foaming additives, thixotropic additives, and any combination thereof. Specific examples of these, and other, additives include crystalline silica, amorphous silica, fumed silica, salts, fibers, hydratable clays, calcined shale, vitrified shale, microspheres, hollow glass spheres, fly ash, diatomaceous earth, metakaolin, ground perlite, rice husk ash, natural pozzolan, zeolite, cement kiln dust, resins, any combination thereof, and the like. A person having ordinary skill in the art, with the benefit of this disclosure, will readily be able to determine the type and amount of additive useful for a particular application and desired result.


Those of ordinary skill in the art will appreciate that embodiments of the settable compositions generally should have a density suitable for a particular application. By way of example, embodiments of the settable compositions may have a density of about 4 pounds per gallon (“lb/gal”) to about 20 lb/gal. In certain embodiments, the settable compositions may have a density of about 8 lb/gal to about 17 lb/gal. Embodiments of the settable compositions may be foamed or unfoamed or may comprise other means to reduce their densities, such as hollow microspheres, low-density elastic beads, or other density-reducing additives known in the art. In addition, the settable composition may comprise weighting agents or other means to increase their densities. Those of ordinary skill in the art, with the benefit of this disclosure, will recognize the appropriate density for a particular application.


In some embodiments, the settable compositions may have a thickening time of greater than about 1 hour, alternatively, greater than about 2 hours, alternatively greater than about 5 hours at 3,000 psi and temperatures in a range of from about 50° F. to about 400° F., alternatively, in a range of from about 80° F. to about 250° F., and alternatively at a temperature of about 140° F. In some embodiments, the settable composition may have a 24-hour compressive strength in a range of from about 100 psi to about 10,000 psi and, alternatively, from about 350 psi about 3,000 psi at atmospheric pressure and temperatures in a range of from about 50° F. to about 400° F., alternatively, in a range of from about 80° F. to about 250° F., and alternatively at a temperature of about 180° F.


The components of the settable composition may be combined in any order desired to form a settable composition that can be placed into a subterranean formation. In addition, the components of the settable compositions may be combined using any mixing device compatible with the composition, including a bulk mixer, for example. In some embodiments, a dry blend may first be formed by the cementitious component or mixture of cementitious components. The dry blend may then be combined with water to form the settable composition. Other suitable techniques may be used for preparation of the settable compositions as will be appreciated by those of ordinary skill in the art in accordance with embodiments of the present invention.


As will be appreciated by those of ordinary skill in the art, embodiments of the cement compositions of the present invention may be used in a variety of cementing operations, including surface and subterranean operations, such as primary and remedial cementing. In some embodiments, a cement composition may be provided that comprises a cementitious component and water, and allowed set. In certain embodiments, the cement composition may be introduced into a subterranean formation and allowed to set therein. As used herein, introducing the cement composition into a subterranean formation includes introduction into any portion of the subterranean formation, including, without limitation, into a well bore drilled into the subterranean formation, into a near well bore region surrounding the well bore, or into both.


In primary-cementing embodiments, for example, embodiments may comprise providing a cement composition, introducing the cement composition into a well-bore annulus; and allowing the cement composition to set in the annulus to form a hardened mass. The well-bore annulus may include, for example, an annular space between a conduit (e.g., pipe string, liner, etc.) and a wall of a well bore or between the conduit and a larger conduit in the well bore. Generally, in most instances, the hardened mass should fix the conduit in the well bore.


In remedial-cementing embodiments, a cement composition may be used, for example, in squeeze-cementing operations or in the placement of cement plugs. By way of example, the cement composition may be placed in a well bore to plug an opening, such as a void or crack in the formation, in a gravel pack, in the conduit, in the cement sheath, and/or a microannulus between the cement sheath and the conduit or formation. An example of such a method may comprise placing the cement composition into the void, and allowing the cement composition to set in the void.


While the preceding description is directed to the use of the cementitious component in cementing methods, it should be understood that embodiments of the present technique also encompasses the use of the cementitious component in any of a variety of different subterranean treatments. The cementitious component may have a reactive index determined according to disclosed embodiments. In some embodiments, a blended cementitious component may be used. In some embodiments, the reactive index may be used in determining the amount of cementitious components that are in a particular blended cementitious component. An example method may include a subterranean treatment method that comprises providing a treatment fluid comprising the cementitious component and introducing the treatment fluid into a subterranean formation. For example, a drilling fluid may comprise the cementitious component, wherein the drilling fluid may be circulated downwardly through a drill pipe and drill bit and then upwardly through the well bore to the surface. The drilling fluid used may be any number of fluids (gaseous or liquid) and mixtures of fluids and solids (such as solid suspensions, mixtures, and emulsions).


In some embodiments, a spacer fluid may comprise the cementitious component, which may have a determined reactive index according to disclosed embodiments. Spacer fluids may be used, for example, in the displacement of fluids from well bore. In an embodiment, the fluid displaced by the spacer fluid comprises a drilling fluid. By way of example, the spacer fluid may be used to displace the drilling fluid from the well bore. The drilling fluid may include, for example, any number of fluids, such as solid suspensions, mixtures, and emulsions. Additional steps in embodiments of the method may comprise introducing a pipe string into the well bore, introducing a cement composition into the well bore with the spacer fluid separating the cement composition and the first fluid. In an embodiment, the cement composition may be allowed to set in the well bore. The cement composition may include, for example, cement and water. In some embodiments, at least a portion of the spacer fluid may be left in the well bore, the spacer fluid in the well bore setting to form a hardened mass.


EXAMPLES

To facilitate a better understanding of the present invention, the following examples of certain aspects of some embodiments are given. In no way should the following examples be read to limit, or define, the entire scope of the invention.


Example 1

The reactive indexes for compressive strength for thirty-three different samples of cement kiln dust, designated Samples A through GG, were determined and are provided in FIG. 1. The CKD samples are each from a different supply source. The reactive indexes for thirty-three CKD samples were determined by dividing the determined 24-hour compressive strength for a settable composition by the specific surface area of the CKD sample. The specific surface area for each CKD sample was determined by dividing the total surface area of the particular CKD sample by the sample mass. The surface area was determined using a Malvern particle size analyzer. The 24-hour compressive strength for each CKD sample was determined by first preparing a settable composition that comprised the CKD sample in an amount of 100% bwoc and water in an amount sufficient to provide a density of about 13 lb/gal. After preparation, the settable composition was allowed to cure for 24 hours in a 2″×4″ metal cylinder that was placed in a water bath at 170° F. to form set cement cylinders. Immediately after removal from the water bath, destructive compressive strengths were deter wined using a mechanical press in accordance with API RP 10B-2.


Example 2

Blended cementitious components were prepared that comprised mixtures of the CKD samples from Example 1, as indicated in the table below. The deter ruined reactive indexes for the CKD samples were then used in the following equation to predict the performance of each blended cementitious component.

CSblend=(RIZ)(SSAZ)(fZ)m+(RIF)(SSAF)(fF)m+(RIE)(SSAE)(fE)m

Wherein CSblend is the estimated compressive strength for the blended cementitious component, RIZ is the reactive index for compressive strength for CKD Sample Z and was 6.9, m is 1, SSAZ is the specific surface area for CKD Sample Z and was 2.32, fZ is the mass fraction of CKD Sample Z, RIF is the reactive index for compressive strength for CKD Sample F and was 105, SSAF is the specific surface area for CKD Sample F and was 2.33, fF is the mass fraction of CKD Sample F, RIE is the reactive index for compressive strength for CKD Sample E and was 107, SSAE is the specific surface area for CKD Sample E and was 3.6, and fE is the mass fraction of CKD Sample E.


The estimated compressive strength values for the blended cementitious components were then compared with the actual 24-hour compressive strength values for the blended cementitious components. The 24-hour compressive strength for each blended cementitious component was determined by first preparing a settable composition that comprised the blended cementitious component in an amount of 100% bwoc and water in an amount sufficient to provide a density of 13 lb/gal. A cement dispersant (CFR-3™ cement friction reducer, from Halliburton Energy Services, Inc.) in an amount of from 0.5% bwoc to 1.0% bwoc was added to some of the samples and should not impact determined compressive strength values. After preparation, the settable composition was allowed to cure for 24 hours in a 2″×4″ metal cylinder that was placed in a water bath at 140° F. to form set cement cylinders. Immediately after removal from the water bath, destructive compressive strengths were determined using a mechanical press in accordance with API RP 10B-2.


A chart of the actual compressive strength values versus the estimated compressive strength values is provided on FIG. 2. As shown on FIG. 2, the charted values have an R2 value of 0.952 and a slope of 0.9253. The estimated and actual compressive strength values for the blended cementitious components are also provided in Table 1 below.













TABLE 1








Estimated
Actual


CKD


Compressive
Compressive


Sample Z
CKD Sample F
CKD Sample E
Strength
Strength


(% bwoc)
(% bwoc)
(% bwoc)
(psi)
(psi)



















100
0
0
16
16


75
25
0
73
51


25
75
0
187
183


0
100
0
244
244


75
0
25
108
84


50
0
50
200
192


25
0
75
292
216


0
0
100
384
384









Example 3

The reactive indexes for volume average apparent viscosity at 511 sec−1 and 51 sec−1 were determined for CKD Samples Z, F, and E from Example 1 and are provided in Table 2 below. The reactive indexes for these samples were determined by dividing the determined volume average apparent viscosity for a settable composition by the specific surface area of the CKD sample. The specific surface area for each CKD sample was determined by dividing the total surface area of the particular CKD sample by the sample mass. The surface area was determined using a Malvern particle size analyzer. The 24-hour volume average apparent viscosity (“VAV”) for each CKD sample was determined by first preparing a settable composition that comprised the CKD sample in an amount of 100% bwoc and water in an amount sufficient to provide a density of about 12 lb/gal. The volume average apparent viscosities were measured at 511 sec−1 and 51 sec−1 in accordance with API RP 10B-2.













TABLE 2







CKD Sample Z
CKD Sample F
CKD Sample E



















SSA
2.32
2.33
3.6


VAV at 511 sec−1 (cp)
11
62
123


RI at 511 sec−1
5
27
32


VAV at 51 sec−1 (cp)
40
410
860


RI at 51 sec−1
17
176
239









Next, blended cementitious components were prepared that comprised mixtures of CKD samples Z, F, E, as indicated in the table below. The determined reactive indexes at 511 sec−1 and 51 sec−1 for the CKD samples were then used in the following equation to predict the performance of each blended cementitious component.

VAVblend=(RIZ)(SSAZ)(fZ)m+(RIF)(SSAF)(fF)m+(RIE)(SSAE)(fE)m

Wherein VAVblend is the estimated volume average apparent viscosity for the blended cementitious component, RIZ is the reactive index for volume average apparent viscosity for CKD Sample Z, SSAZ is the specific surface area for CKD Sample Z, fZ is the mass fraction of CKD Sample Z, m is 7/3, RIF is the reactive index for volume average apparent viscosity for CKD Sample F, SSAF is the specific surface area for CKD Sample F, fF is the mass fraction of CKD Sample F, RIE is the reactive index for volume average apparent viscosity for CKD Sample E, SSAE is the specific surface area for CKD Sample E, and fE is the mass fraction of CKD Sample E.


The estimated volume average apparent viscosities at 511 sec−1 and 51 sec−1 for the blended cementitious components were then compared with the actual volume average apparent viscosities at 511 sec−1 and 51 sec−1 for the blended cementitious components. The volume average apparent viscosities for each blended cementitious component was determined by first preparing a settable composition that comprised the blended cementitious component in an amount of 100% bwoc and water in an amount sufficient to provide a density of 12 lb/gal. After preparation, the volume average apparent viscosities at 511 sec−1 and 51 sec−1 were determined in accordance with API RP 10B-2.


Charts of the actual volume average viscosity values versus the estimated volume average viscosity values are provided on FIGS. 3 and 4. As shown on FIG. 3, the charted values at 511 sec−1 have an R2 value of 0.9894 and a slope of 0.9975. As shown on FIG. 4, the charted values at 51 sec−1 have an R2 value of 0.9931 and a slope of 0.9814. The estimated and actual volume average viscosity values for the blended cementitious components are also provided in Table 2 below.















TABLE 3








Actual
Est.
Actual
Est.


CKD
CKD
CKD
VAV
VAV
VAV
VAV


Sample Z
Sample F
Sample E
@ 511 sec−1
@ 511 sec−1
@ 51 sec−1
@ 51 sec−1


(% bwoc)
(% bwoc)
(% bwoc)
(cp)
(cp)
(cp)
(cp)





















100
0
0
11.0
11.0
40.0
40.0


75
25
0
11.0
8.1
40.0
36.7


25
75
0
24.0
32.2
190.0
211.3


0
100
0
62.0
62.0
410.1
410.0


0
0
100
123.0
123.0
860.2
860.0


25
0
75
66.0
63.4
500.1
441.5


50
0
50
25.0
26.7
160.0
179.0


75
0
25
16.0
10.5
60.0
54.5









It should be understood that the compositions and methods are described in terms of “comprising,” “containing,” or “including” various components or steps, the compositions and methods can also “consist essentially of” or “consist of” the various components and steps. Moreover, the indefinite articles “a” or “an,” as used in the claims, are defined herein to mean one or more than one of the element that it introduces.


For the sake of brevity, only certain ranges are explicitly disclosed herein. However, ranges from any lower limit may be combined with any upper limit to recite a range not explicitly recited, as well as, ranges from any lower limit may be combined with any other lower limit to recite a range not explicitly recited, in the same way, ranges from any upper limit may be combined with any other upper limit to recite a range not explicitly recited. Additionally, whenever a numerical range with a lower limit and an upper limit is disclosed, any number and any included range falling within the range are specifically disclosed. In particular, every range of values (of the form, “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood to set forth every number and range encompassed within the broader range of values even if not explicitly recited. Thus, every point or individual value may serve as its own lower or upper limit combined with any other point or individual value or any other lower or upper limit, to recite a range not explicitly recited.


Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. Although individual embodiments are discussed, the invention covers all combinations of all those embodiments. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. Also, the terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the present invention. If there is any conflict in the usages of a word or term in this specification and one or more patent(s) or other documents that may be incorporated herein by reference, the definitions that are consistent with this specification should be adopted.

Claims
  • 1. A method of cementing comprising: providing a settable composition comprising water and a blended cementitious component, wherein the blended cementitious component comprises kiln dust and an additional cementitious component, wherein the kiln dust is present in the treatment fluid in an amount in a range of from about 0.01% to 99% by weight of the blended cementitious component;deteimining a reactive index of the kiln dust and the additional cementitious component; introducing the settable composition into a well bore; andallowing the settable composition to set to form a hardened mass.
  • 2. The method of claim 1 wherein settable composition is used in primary cementing in the well bore.
  • 3. The method of claim 1 wherein the base fluid comprises water selected from the group consisting of freshwater, saltwater, brine, and any combination thereof, and wherein the kiln dust is selected from the group consisting of lime kiln dust, cement kiln dust, and a combination thereof.
  • 4. The method of claim 1 wherein the kiln dust comprises cement kiln dust.
  • 5. The method of claim 1 wherein the amount of the kiln dust and the additional cementitious component is adjusted based on a parameter selected from the group consisting of compressive strength, Young's modulus, fluid loss, thickening time, a rheological value, free water, and any combination thereof.
  • 6. The method of claim 1 wherein the step of determining the reactive index uses the following equation: RI1=MP1/SSA1
  • 7. The method of claim 6 wherein the measured parameter is compressive strength, Young's modulus, fluid loss, thickening time, a rheological value, free water, or any combination thereof.
  • 8. The method of claim 6 wherein performance of the blended cementitious component is optimized using the following equation: EPblend=(RI1)(SSA1)(f1)m+(RI2)(SSA2)(f2)m
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 13/662,111, filed Oct. 26, 2012, which is a continuation-in-part of U.S. patent application Ser. No. 13/477,777, filed May 22, 2012, which is a divisional of U.S. patent application Ser. No. 13/399,913, filed Feb. 17, 2012, issued as U.S. Pat. No. 8,281,859, which is a continuation-in-part of U.S. patent application Ser. No. 13/180,238, filed Jul. 11, 2011, which is a continuation-in-part of U.S. patent application Ser. No. 12/975,196, filed Dec. 21, 2010, issued as U.S. Pat. No. 8,403,045, and U.S. patent application Ser. No. 13/399,913 is also a continuation-in-part of U.S. patent application Ser. No. 12/895,436, filed Sep. 30, 2010, issued as U.S. Pat. No. 8,522,873, which is a continuation-in-part of U.S. patent application Ser. No. 12/264,010, filed Nov. 3, 2008, issued as U.S. Pat. No. 8,333,240, which is a continuation-in-part of U.S. patent application Ser. No. 11/223,669, filed Sep. 9, 2005, issued as U.S. Pat. No. 7,445,669, the entire disclosures of which are incorporated herein by reference.

US Referenced Citations (390)
Number Name Date Kind
2021956 Gladney et al. Nov 1935 A
2045899 Davis Jun 1936 A
2094316 Cross et al. Sep 1937 A
2133622 Larmour et al. Oct 1938 A
2193775 Stratford Mar 1940 A
2193807 Dieterich Mar 1940 A
2329940 Ponzer Sep 1943 A
2772739 Arie Dec 1956 A
2842205 Allen et al. Jul 1958 A
2848051 Willaims Aug 1958 A
2871133 Palonen et al. Jan 1959 A
2880096 Hurley Mar 1959 A
2945769 Gama et al. Jul 1960 A
3024125 Lee Mar 1962 A
3066031 Schifferle Nov 1962 A
3168139 Kennedy et al. Feb 1965 A
3320077 Prior May 1967 A
3467193 McColl et al. Oct 1968 A
3411580 Roberts et al. Nov 1968 A
3421703 Galer Jan 1969 A
3454095 Messenger et al. Jul 1969 A
3473939 Mayberry et al. Oct 1969 A
3499491 Wyant et al. Mar 1970 A
3557876 Tragesser Jan 1971 A
3574113 Shannon Apr 1971 A
3574816 Abbdellatif et al. Apr 1971 A
3628973 Greening et al. Dec 1971 A
3748159 George Jul 1973 A
3749173 Hill et al. Jul 1973 A
3863718 Bruist Feb 1975 A
3876005 Fincher et al. Apr 1975 A
3887009 Miller et al. Jun 1975 A
3887385 Quist et al. Jun 1975 A
3921717 Danjushevsky et al. Nov 1975 A
3959007 Pitt May 1976 A
4018617 Nicholson Apr 1977 A
4018619 Webster et al. Apr 1977 A
4031184 McCord Jun 1977 A
4036301 Powers et al. Jul 1977 A
4083407 Griffin et al. Apr 1978 A
4101332 Nicholson Jul 1978 A
4105459 Mehta Aug 1978 A
4141843 Watson Feb 1979 A
4176720 Wilson Dec 1979 A
4268316 Wills May 1981 A
4274881 Langton Jun 1981 A
4304300 Watson Dec 1981 A
4333764 Richardson Jun 1982 A
4341562 Ahlbeck Jul 1982 A
RE31190 Detroit et al. Mar 1983 E
4400474 Copperthwaite et al. Aug 1983 A
4407677 Wills Oct 1983 A
4423781 Thomas Jan 1984 A
4432800 Kneller et al. Feb 1984 A
4435216 Diehl et al. Mar 1984 A
4436850 Burdick et al. Mar 1984 A
4440576 Flannery et al. Apr 1984 A
4460292 Durham et al. Jul 1984 A
4462835 Car Jul 1984 A
4470463 Holland Sep 1984 A
4494990 Harris Jan 1985 A
4515635 Rao et al. May 1985 A
4519452 Tsao et al. May 1985 A
4555269 Rao et al. Nov 1985 A
4614599 Walker Sep 1986 A
4624711 Styron Nov 1986 A
4633950 Delhommer et al. Jan 1987 A
4676317 Fry et al. Jun 1987 A
4676832 Childs et al. Jun 1987 A
4741782 Styron May 1988 A
4784223 Worrall et al. Nov 1988 A
4829107 Kindt et al. May 1989 A
4883125 Wilson et al. Nov 1989 A
4941536 Brothers et al. Jul 1990 A
4967839 Carpenter et al. Nov 1990 A
4992102 Barbour Feb 1991 A
5030366 Wilson et al. Jul 1991 A
5049288 Brothers et al. Sep 1991 A
5058679 Hale et al. Oct 1991 A
RE33747 Hartley et al. Nov 1991 E
5086850 Harris et al. Feb 1992 A
5113943 Wilson et al. May 1992 A
5121795 Ewert et al. Jun 1992 A
5123487 Harris et al. Jun 1992 A
5125455 Harris et al. Jun 1992 A
5127473 Harris et al. Jul 1992 A
5183505 Spinney Feb 1993 A
5183506 Zhang Feb 1993 A
5213160 Nahm et al. May 1993 A
5215585 Luthra et al. Jun 1993 A
5238064 Dahl et al. Aug 1993 A
5252128 Gopalkrishnan Oct 1993 A
5266111 Barbour Nov 1993 A
5290355 Jakel et al. Mar 1994 A
5295543 Terry et al. Mar 1994 A
5305831 Nahm Apr 1994 A
5314022 Cowan et al. May 1994 A
5316083 Nahm et al. May 1994 A
5327968 Onan et al. Jul 1994 A
5337824 Cowan Aug 1994 A
5339902 Harris Aug 1994 A
5346548 Mehta Sep 1994 A
5352288 Mallow Oct 1994 A
5358044 Hale et al. Oct 1994 A
5358049 Hale et al. Oct 1994 A
5361841 Hale et al. Nov 1994 A
5361842 Hale et al. Nov 1994 A
5368103 Heathman et al. Nov 1994 A
5370185 Cowan et al. Dec 1994 A
5372641 Carpenter Dec 1994 A
5382290 Nahm et al. Jan 1995 A
5383521 Onan et al. Jan 1995 A
5383967 Chase Jan 1995 A
5398758 Onan et al. Mar 1995 A
5417759 Huddleston May 1995 A
5421409 Muller et al. Jun 1995 A
5423379 Hale et al. Jun 1995 A
5430235 Hooykaas et al. Jul 1995 A
5439056 Cowan Aug 1995 A
5454867 Brothers et al. Oct 1995 A
5456751 Zandi et al. Oct 1995 A
5458195 Totten et al. Oct 1995 A
5464060 Hale et al. Nov 1995 A
5472051 Brothers Dec 1995 A
5476144 Nahm et al. Dec 1995 A
5484019 Griffith Jan 1996 A
5494513 Fu et al. Feb 1996 A
5499677 Cowan Mar 1996 A
5515921 Cowan et al. May 1996 A
5518996 Maroy et al. May 1996 A
5520730 Barbour May 1996 A
5529123 Carpenter et al. Jun 1996 A
5529624 Riegler Jun 1996 A
5536311 Rodrigues Jul 1996 A
5542782 Carter et al. Aug 1996 A
5554352 Jaques et al. Sep 1996 A
5569324 Totten et al. Oct 1996 A
5571318 Griffith et al. Nov 1996 A
5580379 Cowan Dec 1996 A
5584926 Borgholm et al. Dec 1996 A
5585333 Dahl et al. Dec 1996 A
5588489 Chatterji et al. Dec 1996 A
5641584 Andersen et al. Jun 1997 A
5673753 Hale et al. Oct 1997 A
5681384 Liskowitz et al. Oct 1997 A
5688844 Chatterji et al. Nov 1997 A
5711383 Terry et al. Jan 1998 A
5716910 Totten et al. Feb 1998 A
5728654 Dobson et al. Mar 1998 A
5789352 Carpenter Aug 1998 A
5795924 Chatterji et al. Aug 1998 A
5820670 Chatterji et al. Oct 1998 A
5851960 Totten et al. Dec 1998 A
5866516 Costin Feb 1999 A
5866517 Carpenter et al. Feb 1999 A
5874387 Carpenter et al. Feb 1999 A
5897699 Chatterji et al. Apr 1999 A
5900053 Brothers et al. May 1999 A
5913364 Sweatman Jun 1999 A
5968255 Metha et al. Oct 1999 A
5988279 Udarbe et al. Nov 1999 A
6022408 Stokes et al. Feb 2000 A
6060434 Sweatman et al. May 2000 A
6060535 Villar et al. May 2000 A
6063738 Chatterji et al. May 2000 A
6098711 Chatterji et al. Aug 2000 A
6138759 Chatterji et al. Oct 2000 A
6143069 Brothers et al. Nov 2000 A
6145591 Boncan et al. Nov 2000 A
6153562 Villar et al. Nov 2000 A
6167967 Sweatman Jan 2001 B1
6170575 Reddy et al. Jan 2001 B1
6230804 Mueller et al. May 2001 B1
6244343 Brothers et al. Jun 2001 B1
6245142 Reddy et al. Jun 2001 B1
6258757 Sweatman et al. Jul 2001 B1
6264738 Lorke et al. Jul 2001 B1
6277189 Chugh Aug 2001 B1
6312515 Barlet-Gouedard et al. Nov 2001 B1
6315042 Griffith et al. Nov 2001 B1
6328106 Griffith et al. Dec 2001 B1
6332921 Brothers et al. Dec 2001 B1
6367550 Chatterji et al. Apr 2002 B1
6379456 Heathman et al. Apr 2002 B1
6402833 O'Hearn et al. Jun 2002 B1
6409819 Ko Jun 2002 B1
6416574 Steelhammer et al. Jul 2002 B1
6451104 Mehta Sep 2002 B2
6457524 Roddy Oct 2002 B1
6478869 Reddy et al. Nov 2002 B2
6478870 Marko Nov 2002 B2
6488763 Brothers et al. Dec 2002 B2
6488764 Westerman Dec 2002 B2
6494951 Reddy et al. Dec 2002 B1
6500252 Chatterji et al. Dec 2002 B1
6502634 Evans et al. Jan 2003 B1
6508305 Brannon et al. Jan 2003 B1
6516884 Chatterji et al. Feb 2003 B1
6524384 Griffith et al. Feb 2003 B2
6547871 Chatterji et al. Apr 2003 B2
6547891 Linden et al. Apr 2003 B2
6561273 Brothers et al. May 2003 B2
6562122 Dao et al. May 2003 B2
6565647 Day et al. May 2003 B1
6572697 Gleeson et al. Jun 2003 B2
6610139 Crook et al. Aug 2003 B2
6626243 Go Boncan Sep 2003 B1
6641658 Dubey Nov 2003 B1
6645289 Sobolev et al. Nov 2003 B2
6645290 Barbour Nov 2003 B1
6656265 Garnier et al. Dec 2003 B1
6660080 Reddy et al. Dec 2003 B2
6666268 Griffith et al. Dec 2003 B2
6668927 Chatterji et al. Dec 2003 B1
6668929 Griffith et al. Dec 2003 B2
6689208 Brothers Feb 2004 B1
6702044 Reddy et al. Mar 2004 B2
6706108 Polston Mar 2004 B2
6708760 Chatterji et al. Mar 2004 B1
6715568 Bailey Apr 2004 B1
6716282 Griffith et al. Apr 2004 B2
6729405 DiLullo et al. May 2004 B2
6755905 Oates Jun 2004 B2
6767398 Trato Jul 2004 B2
6776237 Dao et al. Aug 2004 B2
6796378 Reddy et al. Sep 2004 B2
6797054 Chatterji et al. Sep 2004 B2
6823940 Reddy et al. Nov 2004 B2
6832652 Dillenbeck et al. Dec 2004 B1
6835243 Brothers et al. Dec 2004 B2
6837316 Reddy et al. Jan 2005 B2
6840318 Lee Jan 2005 B2
6840996 Morioka et al. Jan 2005 B2
6846357 Reddy et al. Jan 2005 B2
6848519 Reddy et al. Feb 2005 B2
6869474 Perez-Pena et al. Mar 2005 B2
6869475 Krowl Mar 2005 B1
6874578 Garnier Apr 2005 B1
6883609 Drochon et al. Apr 2005 B2
6887833 Brothers et al. May 2005 B2
6889767 Reddy et al. May 2005 B2
6899177 Chatterj et al. May 2005 B2
6904971 Brothers et al. Jun 2005 B2
6908507 Lalande et al. Jun 2005 B2
6908508 Brothers Jun 2005 B2
6911078 Barlet-Gouedard et al. Jun 2005 B2
6964302 Luke et al. Nov 2005 B2
6989057 Getzlaf et al. Jan 2006 B2
7022755 Chatterji et al. Apr 2006 B1
7048053 Santra et al. May 2006 B2
7055603 Caveny et al. Jun 2006 B2
7073584 Reddy et al. Jul 2006 B2
7073585 Morgan et al. Jul 2006 B2
7077203 Roddy et al. Jul 2006 B1
7090721 Craig et al. Aug 2006 B2
7096944 Vargo et al. Aug 2006 B2
7101829 Guichard Sep 2006 B2
7137446 Gagliano et al. Nov 2006 B2
7140439 Luke et al. Nov 2006 B2
7140440 Luke et al. Nov 2006 B2
7143827 Chatterji et al. Dec 2006 B2
7147055 Brothers et al. Dec 2006 B2
7147067 Getzlaf et al. Dec 2006 B2
7150321 Luke et al. Dec 2006 B2
7174962 Roddy et al. Feb 2007 B1
7182137 Fyten et al. Feb 2007 B2
7198104 Griffith et al. Apr 2007 B2
7199086 Roddy et al. Apr 2007 B1
7204307 Roddy et al. Apr 2007 B2
7204310 Roddy et al. Apr 2007 B1
7213646 Roddy et al. May 2007 B2
7217441 Bour et al. May 2007 B2
7219733 Luke et al. May 2007 B2
7255739 Brothers et al. Aug 2007 B2
7284609 Roddy et al. Oct 2007 B2
7284930 Shi et al. Oct 2007 B2
7285164 Luke et al. Oct 2007 B2
7293609 Dealy et al. Nov 2007 B2
7297664 Santra et al. Nov 2007 B2
7303008 Badalamenti et al. Dec 2007 B2
7316744 De La Roij et al. Jan 2008 B2
7325611 Santra et al. Feb 2008 B2
7335252 Roddy et al. Feb 2008 B2
7337842 Roddy et al. Mar 2008 B2
7338923 Roddy et al. Mar 2008 B2
7341104 Roddy et al. Mar 2008 B2
7341105 Bingamon et al. Mar 2008 B2
7350573 Reddy Apr 2008 B2
7353870 Roddy et al. Apr 2008 B2
7381263 Roddy et al. Jun 2008 B2
7387675 Roddy et al. Jun 2008 B2
7395860 Roddy et al. Jul 2008 B2
7404855 Chatterji et al. Jul 2008 B2
7409990 Burts et al. Aug 2008 B1
7413014 Chatterji et al. Aug 2008 B2
7442249 Mueller Oct 2008 B2
7445669 Roddy et al. Nov 2008 B2
7478675 Roddy et al. Jan 2009 B2
7488762 Takano et al. Feb 2009 B2
7527688 Bingamon et al. May 2009 B2
7544640 Luke et al. Jun 2009 B2
7607482 Roddy et al. Oct 2009 B2
7607484 Roddy et al. Oct 2009 B2
7627870 Michaeli et al. Dec 2009 B1
7631692 Roddy et al. Dec 2009 B2
7651563 Datta et al. Jan 2010 B2
7655088 Bethani Feb 2010 B2
7658796 Nordmeyer Feb 2010 B2
7674332 Roddy et al. Mar 2010 B2
7712527 Roddy May 2010 B2
7740070 Santra et al. Jun 2010 B2
7741841 Edwards et al. Jun 2010 B2
7743828 Roddy et al. Jun 2010 B2
7748454 Roddy et al. Jul 2010 B2
7757766 Lewis Jul 2010 B2
7784542 Roddy et al. Aug 2010 B2
7789150 Roddy et al. Sep 2010 B2
7815880 Constantz et al. Oct 2010 B2
7837412 O'Hearn Nov 2010 B2
7867954 Warrender et al. Jan 2011 B2
7887694 Constantz et al. Feb 2011 B2
7919064 Kawatra et al. Apr 2011 B2
7922809 Constantz et al. Apr 2011 B1
7927419 Roddy Apr 2011 B2
7939336 Constantz et al. May 2011 B2
7963323 Bailey Jun 2011 B2
7993451 Brouillette et al. Aug 2011 B2
8006446 Constantz et al. Aug 2011 B2
8029618 Al-Shafei Oct 2011 B2
8030253 Roddy et al. Oct 2011 B2
8039253 Asou Oct 2011 B2
8075687 Testud Dec 2011 B2
8162055 Lewis et al. Apr 2012 B2
8261827 Roddy Sep 2012 B2
8297357 Brenneis et al. Oct 2012 B2
8307899 Brenneis et al. Nov 2012 B2
8318642 Roddy et al. Nov 2012 B2
8324137 Roddy et al. Dec 2012 B2
8327939 Roddy et al. Dec 2012 B2
8333240 Roddy et al. Dec 2012 B2
8342242 Roddy et al. Jan 2013 B2
8394744 Woytowich et al. Mar 2013 B2
8399387 Roddy et al. Mar 2013 B2
8403045 Brenneis et al. Mar 2013 B2
8434553 Brenneis et al. May 2013 B2
8440596 Brenneis et al. May 2013 B2
8470275 Constantz et al. Jun 2013 B2
8486868 Brenneis et al. Jul 2013 B2
8486869 Brenneis et al. Jul 2013 B2
8505629 Benkley et al. Aug 2013 B2
8505630 Chatterji et al. Aug 2013 B2
8522873 Benkley et al. Sep 2013 B2
8540025 Reddy et al. Sep 2013 B2
8544543 Chatterji et al. Oct 2013 B2
8551923 Benkley et al. Oct 2013 B1
8554543 Cherepanov et al. Oct 2013 B2
8555967 Chatterji et al. Oct 2013 B2
8586508 Reddy et al. Nov 2013 B2
8586512 Roddy et al. Nov 2013 B2
8598093 Roddy et al. Dec 2013 B2
8603951 Perez Dec 2013 B2
8609595 Morgan Dec 2013 B2
20020117090 Ku Aug 2002 A1
20030116887 Scott Jun 2003 A1
20040187740 Timmons Sep 2004 A1
20060166834 Roddy Jul 2006 A1
20070056479 Gray Mar 2007 A1
20070137528 LeRoy-Delage et al. Jun 2007 A1
20070265173 Al-Shafei Nov 2007 A1
20080087472 Fout Apr 2008 A1
20080229979 Lewis Sep 2008 A1
20090124522 Roddy et al. May 2009 A1
20090298724 Getzlaf et al. Dec 2009 A1
20100044057 Dealy et al. Feb 2010 A1
20100196104 Constantz et al. Aug 2010 A1
20100258035 Constantz et al. Oct 2010 A1
20110000400 Roddy Jan 2011 A1
20120152539 Karcher Jun 2012 A1
20120227631 Roddy Sep 2012 A1
20120285682 Santra et al. Nov 2012 A1
20120318506 Benkley et al. Dec 2012 A1
20120325476 Brenneis et al. Dec 2012 A1
20120328377 Brenneis et al. Dec 2012 A1
20130008352 Roddy et al. Jan 2013 A1
20130118752 Hannegan et al. May 2013 A1
20130126159 Bryan et al. May 2013 A1
20130153214 Roddy et al. Jun 2013 A1
20130157903 Benkley et al. Jun 2013 A1
20130210685 Chatterji et al. Aug 2013 A1
20130213643 Chatterji et al. Aug 2013 A1
Foreign Referenced Citations (42)
Number Date Country
2064682 Apr 1992 CA
2336077 Jan 2000 CA
2153372 Jan 2006 CA
2736148 May 2012 CA
1054620 Nov 1997 CN
1182062 May 1998 CN
200680042014.3 Dec 2010 CN
0814067 Dec 1997 EP
1092693 Apr 2001 EP
1236701 Sep 2002 EP
1394137 Jul 2003 EP
1348831 Oct 2003 EP
1900703 Mar 2008 EP
2075303 Jul 2009 EP
1469954 Apr 1997 GB
2455446 Jun 2009 GB
52117316 Oct 1977 JP
10110487 Apr 1998 JP
2026959 Jan 1995 RU
2003136028 May 2005 RU
2008113765 Jul 2009 RU
1373781 Feb 1988 SU
WO 8301443 Sep 1982 WO
WO 9321122 Oct 1993 WO
WO 9721637 Jun 1997 WO
WO 9854108 Dec 1998 WO
WO 0063134 Jan 2000 WO
WO 03031364 Apr 2003 WO
WO 2004101951 Nov 2004 WO
WO 2004101952 Nov 2004 WO
WO 2005047212 May 2005 WO
WO 2005061846 Jul 2005 WO
WO 2006032841 Mar 2006 WO
2007028951 Mar 2007 WO
WO 2007028952 Mar 2007 WO
WO 2007041841 Apr 2007 WO
WO 2007048999 May 2007 WO
WO 2007128945 Nov 2007 WO
WO 2009071962 Dec 2007 WO
WO 2006074946 Jun 2009 WO
WO 2009138747 Nov 2009 WO
WO 2012001343 Jan 2012 WO
Non-Patent Literature Citations (182)
Entry
USPTO Office Action for U.S. Appl. No. 13/662,155 Dated Sep. 25, 2014.
USPTO Office Action for U.S. Appl. No. 13/955,516 dated Dec. 19, 2013.
USPTO Office Action for U.S. Appl. No. 13/851,475 dated Jan. 24, 2014.
USPTO Notice of Allowance for U.S. Appl. No. 13/180,238 dated Jan. 22, 2014.
USPTO Notice of Allowance for U.S. Appl. No. 13/851,925 dated Jan. 24, 2014.
International Search Report and Written Opinion for Application No. PCT/US2013/066771 dated Dec. 26, 2013.
Hall, “Bridging Effectiveness of Perlite for Light Weight Cements and Lost Circulation”, Petroleum Branch, AIME, Paper No. 141-G, Oct. 1951.
Saunders, “Trend in Use of Low-weight Cement Slurries”, Abstract, Mar. 1952.
Murphy,“A Critique of Filler Cements”, Journal of Petroleum Technology, Aug. 1967.
Sugama, “Carbonation of Hydrothermally Treated Phosphate-Bonded Calcium Aluminate Cements”, pp. 1-9, 1973.
Herndon, “Setting Downhole Plugs: A State-of-the-Art”, Petroleum Engineer International, Apr. 1978.
“API Specification for Materials and Testing for Well Cements”, API Spec. 10, 5th ed., pp. 7, 19-21, Jul. 1, 1980.
Sersale, “Portland-Zeolite-Cement for Minimizing Alkali-Aggregate Expansion”, 1987.
Smith, “Cementing” Society of Professional Engineers, pp. 14, 38, 1987.
Nelson, “Well Cementing”, 1990.
Smith, “Cementing” Society of Petroleum Engineers, p. 38, 1990.
“Appendix A”, API RP 13B-2, 2d ed.; pp. 6-8, Dec. 1, 1991.
Sugama, “Carbonation of Hydrothermally Treated Phosphate Bonded Calcium Aluminate Cements,” pp. 1-10, 1992.
Vinson, “Acid Removable Cement System Helps Lost Circulation in Productive Zones”, IADC/SPE 23929, Feb. 18, 1992.
Marfil, “Zeolite Crystallization in Portland Cement Concrete Due to Alkali-Aggregate Reaction”, 1993.
Atkins, “Zeolite P in Cements”, “Its Potential for Immobilizing Toxic and Radioactive Waste Species”, 1995.
Janotka, “The Properties of Mortar Using Blends With Portland Cement Clinker, Zeolite Tuff and Gypsum”, 1995.
“Manufacture of supplementary cementitious materials from cement kiln dust”, Mishulovich et al., World Cement Research and Development, p. 116-120, Mar. 1996.
Sugama, “Hot Alkali Carbonation of Sodium Metaphosphate Modified Fly Ash/Calcium Aluminate Blend Hydrothermal Cements”, pp. 1661-1672, Sep. 11, 1996.
Rogers, “Designing a Remedial Acid Treatment for Gulf of Mexico Deepwater Turbidite Sands Containing Zeolite Cement”, 1996.
Janotka, “Effect of Bentonite and Zeolite on Durability of Cement Suspension Under Sulfate Attack”, 1998.
Naiqian, “Study on the Suppression Effect of Natural Zeolite on Expansion of Concrete Due to Alkali-Aggregate Reaction”, 1998.
Chan, Comparative Study of the Initial Surface Absorption and Chloride Diffusion of High Performance Zeolite Silica Fume and PFA concretes, 1999.
Poon, “A Study of the Hydration of Natural Zeolite Blended Cement Pastes”, 1999.
Ding, “Extreme Vertices Design of Concrete With Combined Mineral Admixtures”, 1999.
Feng, “Zeolite Ceramiste Cellular Concrete”, 2000.
Bartlet-Gouedard, “A Non-Conventional Way of Developing Cement Slurry for Geothermal Wells”, 2001.
TXI Material Safety Data Sheet for Pressur-Seal, Oct. 2003.
“Kiln Dusts”, Apr. 14, 2005.
“Beneficial use of Solid Waste in Maine”, Apr. 14, 2005.
“Standards for the Management of Cement Kiln Dust Waste”, Apr. 14, 2005.
“Use of Cement Kiln Dust for the Stabilization of Soils”, R. L. Parsons, et al., Apr. 14, 2005.
“Alkali-activated binders by use of industrial by-products”, Buchwald et al., Cement and concrete Research 35, p. 968-973, 2005.
Answer 3 of 24 Chemical Abstracts on STN “Effect of cement kiln dust substitution on chemical and physical properties and compressive strength of Portland and slag cements”, Adb El-aleem et al. (abstract only), 2005.
Adaska and Taubert, “Beneficial Uses of Cement Kiln Dust”, 2008 IEEE/PCA 50th Cement Industry technical Conference, Miami, FL, May 19-22, 2008, pp. 1-19, 2008.
“Fly Ash Resource Center-Pozzolan,” available at http://www.rmajko.com/pozzolan.htm, Apr. 20, 2009.
Suyan, “An innovative Material for Severe Lost Circulation Control in Depleted Formations” SPE/IADC 125693, Oct. 2009.
The Schundler Company, “Perlite as an Ultra Fine Filler”, Schundler Product Guide, http://www.schundler.com/filler.htm, 2010.
IP.com Electronic Publication, “Use of Cement Kiln Dust (CKD) in Low Temperature Cementing to Reduce Transition Times”, Sep. 25, 2013.
HES Brochure “SCR-100 Cement Retarder a Valuable Time Saver”, 1994.
HES Brochure “Halad-344 Fluid Loss Additive”, 1998.
HES Brochure “HR-5 Cement Additive”, 1998.
HES Brochure “AQF-2 Foaming Agent”, 1999.
HES Brochure “ThermaLock™ Cement for Corrosive CO2 Environments”, 1999.
HES Brochure “Halad-413 Fluid Loss Additive”, 1999.
HES Brochure “Howco Suds Surfactant”, 1999.
HES Brochure “HR-12 Cement Retarder”, 1999.
HES Brochure “HR-15 Cement Retarder”, 1999.
HES Brochure “HR-25 Cement Retarder”, 1999.
HES Brochure “HR-4 Cement Retarder”, 1999.
HES Brochure “HR-7 Cement Retarder”, 1999.
HES Brochure “Pozmix A Cement Additive”, 1999.
HES Brochure “Pozmix Cement and Pozmix 140”, 1999.
HES Brochure “SCR-100™ Cement Retarder”, 1999.
HES Brochure “SCR-500L High Temp Retarder”, 2000.
HES Brochure “Halad-23 Fluid Loss Additive”, 2000.
HES Brochure “Thermatek Service”, May 2005.
HES “Cementing-Perlite Cement Additive”, Aug. 2007.
HES Brochure “Thermatek® RSP Rapid Set Plug Service”, Mar. 2008.
“3M Scotchlite, Glass Bubbles Floated Product Series Product Information”, 1999.
LaFarge MSDS “Cement Kiln Dust”, Mar. 3, 2005.
LaFarge MSDS “LaFarge Blended Cement (cement)”, Mar. 3, 2005.
LaFarge brochure “TerraCem™”, Aug. 2006.
Office Action from U.S. Appl. No. 11/223,671, Dec. 15, 2005.
Office Action from U.S. Appl. No. 11/271,431, Mar. 6, 2006.
Office Action from U.S. Appl. No. 11/223,671, Mar. 31, 2006.
Office Action from U.S. Appl. No. 11/271,431, May 17, 2006.
Office Action from U.S. Appl. No. 11/271,431 (Advisory Action), Jul. 11, 2006.
Office Action from U.S. Appl. No. 11/416,563, Jul. 21, 2006.
Office Action from U.S. Appl. No. 11/403,032, Jul. 24, 2006.
Office Action from U.S. Appl. No. 11/271,431, Aug. 15, 2006.
Office Action from U.S. Appl. No. 11/440,627, Aug. 21, 2006.
Office Action from U.S. Appl. No. 11/402,741, Oct. 19, 2006.
Office Action from U.S. Appl. No. 11/484,951, Oct. 26, 2006.
Office Action from U.S. Appl. No. 11/484,951, Dec. 21, 2006.
Office Action from U.S. Appl. No. 11/223,703, Jan. 17, 2007.
Office Action from U.S. Appl. No. 11/402,741, Feb. 2, 2007.
Office Action from U.S. Appl. No. 11/223,485, Feb. 28, 2007.
Office Action from U.S. Appl. No. 11/223,669, Feb. 28, 2007.
Office Action from U.S. Appl. No. 11/271,690, Mar. 13, 2007.
Office Action from U.S. Appl. No. 11/402,741, Mar. 22, 2007.
Office Action from U.S. Appl. No. 11/223,703, Apr. 25, 2007.
Office Action from U.S. Appl. No. 11/402,741, May 29, 2007.
Office Action from U.S. Appl. No. 11/223,669, Jun. 18, 2007.
Office Action from U.S. Appl. No. 11/257,261, Aug. 10, 2007.
Office Action from U.S. Appl. No. 11/402,741, Sep. 6, 2007.
Office Action from U.S. Appl. No. 11/223,669, Oct. 9, 2007.
Office Action from U.S. Appl. No. 11/223,750, Oct. 16, 2007.
Office Action from U.S. Appl. No. 11/402,741, Oct. 24, 2007.
Office Action from U.S. Appl. No. 11/223,669, Jan. 29, 2008.
Office Action from U.S. Appl. No. 11/223,669, Apr. 8, 2008.
Office Action from U.S. Appl. No. 12/263,800, May 1, 2009.
Office Action from U.S. Appl. No. 12/283,398, Jul. 15, 2009.
Office Action from U.S. Appl. No. 12/263,800, Jul. 28, 2009.
Office Action from U.S. Appl. No. 12/420,630, Aug. 3, 2009.
Office Action from U.S. Appl. No. 12/349,676, Nov. 4, 2009.
Office Action from U.S. Appl. No. 12/606,381, Mar. 23, 2010.
Office Action from U.S. Appl. No. 12/609,993, Apr. 9, 2010.
Office Action from U.S. Appl. No. 12/609,993, Jun. 15, 2010.
Office Action from U.S. Appl. No. 12/558,097, Jun. 20, 2010.
Notice of Allowance from U.S. Appl. No. 12/609,993, Jul. 26, 2010.
Office Action from U.S. Appl. No. 12/558,097, Sep. 3, 2010.
Office Action from U.S. Appl. No. 12/833,189, Oct. 1, 2010.
Office Action from U.S. Appl. No. 12/844,612, Oct. 1, 2010.
Office Action from U.S. Appl. No. 12/364,998, Jan. 14, 2011.
Office Action from U.S. Appl. No. 12/844,612, Jan. 28, 2011.
Notice of Allowance from U.S. Appl. No. 12/544,915, Aug. 1, 2011.
Office Action from U.S. Appl. No. 12/844,612, Sep. 6, 2011.
Office Action from U.S. Appl. No. 12/264,010, Oct. 31, 2011.
Final Office Action from U.S. Appl. No. 12/844,612, Dec. 23, 2011.
Final Office Action from U.S. Appl. No. 12/264,010, Apr. 10, 2012.
Office Action from U.S. Appl. No. 12/844,612, Apr. 11, 2012.
Office Action from U.S. Appl. No. 13/399,913, May 15, 2012.
Office Action from U.S. Appl. No. 13/447,560, May 31, 2012.
Office Action from U.S. Appl. No. 12/821,412, Jun. 5, 2012.
Office Action from U.S. Appl. No. 12/825,004, Jun. 14, 2012.
Notice of Allowance from U.S. Appl. No. 13/447,560, Jun. 21, 2012.
Office action from U.S. Appl. No. 13/479,476, Jul. 2, 2012.
Office action from U.S. Appl. No. 12/975,196, Jul. 3, 2012.
Final Office Action from U.S. Appl. No. 12/844,612, Jul. 30, 2012.
Notice of Allowance from U.S. Appl. No. 13/399,913, Aug. 23, 2012.
Notice of Allowance from U.S. Appl. No. 13/535,258, Sep. 7, 2012.
Notice of Allowance from U.S. Appl. No. 12/825,004, Sep. 20, 2012.
Office Action from U.S. Appl. No. 13/477,777, Oct. 15, 2012.
Office Action from U.S. Appl. No. 13/560,406, Oct. 17, 2012.
Notice of Allowance from U.S. Appl. No. 12/844,612, Oct. 18, 2012.
Office Action from U.S. Appl. No. 13/555,624, Oct. 19, 2012.
Final Office Action from U.S. Appl. No. 12/975,196, Oct. 23, 2012.
Office Action from U.S. Appl. No. 13/431,701, Nov. 9, 2012.
Office Action from U.S. Appl. No. 13/620,163, Nov. 9, 2012.
Office Action from U.S. Appl. No. 13/606,098, Dec. 13, 2012.
Office Action from U.S. Appl. No. 13/669,149, Dec. 19, 2012.
Office Action from U.S. Appl. No. 13/620,013, Feb. 26, 2013.
Office Action from U.S. Appl. No. 13/725,833, Apr. 10, 2013.
Notice of Allowance from U.S. Appl. No. 13/669,149, May 13, 2013.
Notice of Allowance form U.S. Appl. No. 13/535,145, May 24, 2013.
Office Action from U.S. Appl. No. 13/620,013, May 28, 2013.
Notice of Allowance from U.S. Appl. No. 12/895,436, May 28, 2013.
Final Office Action from U.S. Appl. No. 13/477,777, May 29, 2013.
Notice of Allowance from U.S. Appl. No. 13/560,406, May 29, 2013.
Office Action from U.S. Appl. No. 13/851,925, Jun. 6, 2013.
Office Action from U.S. Appl. No. 13/889,398, Jun. 20, 2013.
Office Action from U.S. Appl. No. 13/851,391, Jul. 3, 2013.
Office Action from U.S. Appl. No. 13/872,063, Jul. 12, 2013.
Office Action from U.S. Appl. No. 13/767,710, Jul. 19, 2013.
Notice of Allowance from U.S. Appl. No. 13/851,391, Jul. 31, 2013.
Notice of Allowance from U.S. Appl. No. 13/889,398, Aug. 20, 2013.
Final Office Action from U.S. Appl. No. 13/477,777, Sep. 20, 2013.
Office Action from U.S. Appl. No. 13/767,710, Sep. 20, 2013.
Final Office Action from U.S. Appl. No. 13/851,925, Sep. 20, 2013.
Office Action from U.S. Appl. No. 13/180,238, Sep. 25, 2013.
Final Office Action from U.S. Appl. No. 13/620,013, Oct. 2, 2013.
Notice of Allowance from U.S. Appl. No. 13/662,111, Oct. 21, 2013.
Foreign Search Report from PCT/GB2005/001415, Sep. 9, 2005.
Foreign Search Report from PCT/GB2006/000406, Jul. 5, 2006.
Foreign Search Report from PCT/GB2006/003163, Oct. 27, 2006.
Foreign Search Report from PCT/GB2006/003160, Nov. 2, 2006.
Foreign Search Report from PCT/GB2006/003735, Dec. 1, 2006.
Foreign Search Report from PCT/GB2006/003694, Dec. 19, 2006.
Foreign Search Report from PCT/GB2006/000401, May 8, 2007.
Foreign Search Report from PCT/GB2009/000295, Feb. 3, 2009.
Foreign Search Report from PCT/GB2011/001749, Apr. 5, 2012.
EPO Application No. 06779194.7 Examination Report, May 29, 2009.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2009/000295, Jul. 30, 2009.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2009/002597, Feb. 1, 2010.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2009/002598, Feb. 11, 2010.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2010/000712, Jul. 26, 2010.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2009/000295, Aug. 24, 2010.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2010/001986, Jan. 19, 2011.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2010/002011, Feb. 4, 2011.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2009/002018, Mar. 24, 2011.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2011/000933, Sep. 22, 2011.
PCT International Search Report and Written Opinion for International Application No. PCT/GB2011/001411, Jan. 27, 2012.
PCT International Search Report and Written Opinion for International Application No. PCT/US2012/046117, Oct. 26, 2012.
PCT International Search Report and Written Opinion for International Application No. PCT/US2013/056719, Oct. 25, 2013.
PCT International Search Report and Written Opinion for International Application No. PCT/US2013/048092, Nov. 13, 2013.
U.S. Appl. No. 13/622,821, first named inventor Brenneis et. al., filed Sep. 19, 2012.
Related Publications (1)
Number Date Country
20140048266 A1 Feb 2014 US
Divisions (1)
Number Date Country
Parent 13399913 Feb 2012 US
Child 13477777 US
Continuations (1)
Number Date Country
Parent 13662111 Oct 2012 US
Child 14061364 US
Continuation in Parts (6)
Number Date Country
Parent 13477777 May 2012 US
Child 13662111 US
Parent 13180238 Jul 2011 US
Child 13399913 US
Parent 12975196 Dec 2010 US
Child 13180238 US
Parent 12895436 Sep 2010 US
Child 13399913 Feb 2012 US
Parent 12264010 Nov 2008 US
Child 12895436 US
Parent 11223669 Sep 2005 US
Child 12264010 US